Trial Profile
Phase II trial of hypericin photodynamic therapy in patients with cutaneous T-cell lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Feb 2017
Price :
$35
*
At a glance
- Drugs Hypericin sodium (Primary)
- Indications Cutaneous T-cell lymphoma
- Focus Therapeutic Use
- Sponsors HY BIOPHARMA
- 16 Sep 2014 New trial record
- 05 Sep 2014 Results published in the Media Release.